REGN Regeneron Pharmaceuticals Inc
NASDAQ · USD · scheduled refresh; check source timestamp Insiders net selling (90d) — usually routine☪ Shariah-compliant · TEST$784.85
-4.60 (-0.58%)
Price session: 2026-09-18 · Observed: 18 Sept 2026, 23:00 KSA · Source: live quote
56
Easy Score
NeutralOne number from three engines — value 63، momentum 46، trend 60 (0–100). Analysis, not financial advice.
Why is it moving? auto-generated from price, volume, signals, news
REGN -0.58% today · volume 4.1× the 20-day average — unusual activity · 3 recent headlines — latest not assessed: “Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent Loss”.
Price interactive — your checked tools draw on it
Daily is the finest granularity · last ~6 months
RSI (14)
Patterns detected:
CloseMA 50MA 200check tools below to add them to the chart
Key technicals & risk same math as the same engine as the Overview page
RSI (14)47.8
MACD hist.-8.03
50-day MA$763.57
200-day MA$733.80
ATR (14)$18.88
Avg volume (20d)0.7M
Volatility (ann.)34%
Max drawdown (1y)-26%
Beta vs S&P0.51
Daily plain-language briefs are a Pro feature.
Forecast two independent reads
System
USD 766.54USD 806.78
Yours · 2 toolsUSD 774.99USD 815.68
NowUSD 784.85USD 763.59USD 818.63
Computed from: USD 784.85 · session 2026-09-18 · 2509 historical windows
Lean score +0.43 — 1 bullish / 0 bearish / 1 neutral among your checked tools, weighted for this horizon. Your overlay is an exploratory scenario, not a calibrated prediction. The historical baseline stays unchanged. The system band is the 25th–75th percentile of this stock's own historical moves for the horizon.
Technical indicators
Checked 2 of 2 allowed on Free plan
Sign in to save your tool selection per stock.
Street consensus: 26 buy / 12 hold / 0 sell of 38 analysts
My notes on REGN private investment journal
Sign in to keep a dated journal per stock — your thesis lives next to the data.